Horizon Therapeutics Public Limited Company is a company in the U.S. stock market and it is a holding in 135 U.S.-traded ETFs. HZNP has around 13.6M shares in the U.S. ETF market. The largest ETF holder of HZNP is the Vanguard Mid-Cap ETF (VO), with approximately 1.61M shares. Investors may also find of interest that the ETF with the largest allocation to HZNP stock is Invesco DWA Healthcare Momentum ETF (PTH), with a portfolio weight of 4.85%. On average, U.S. ETFs allocate 0.45% of HZNP to their portfolios.
Additionally, HZNP is a favorite stock for Multi-factor and Vanilla ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with HZNP as a holding is the Invesco RAFI Strategic US Small Company ETF (IUSS), with a return of 69.76%.